Indian Pharma Machinery Makers Go For Overseas Tie-Ups For Growth
The pharmaceutical machinery manufacturing industry in the country, with more
than 600 players of various sizes, is all set for a major boom with several
domestic players prefer to either set up a joint venture company or enter
technical collaboration with overseas firms.
According to industry sources, domestic pharma machine manufacturers are
increasingly exploring technical collaborations and partnerships with overseas
firms to innovate and share novel technologies. As several key players in the
segment are looking towards advanced markets like the US and Europe,
collaborations and joint ventures with the overseas firms are of great advantage
to the domestic players.
The tie-ups with the overseas firms are expected to facilitate domestic
companies to explore new geographical locations and access to the latest
technological developments in the segment.
Some of the key players in the segment, which have either entered or plans to
enter collaborations and joint ventures with the overseas firms are ACG world
wide, Elmach Packages India Pvt. Ltd. and Parle Pharma Machineries.
Commenting on the joint ventures between domestic and international companies,
Saurabh Upadhyay, executive director, Tax & Regulatory Services, Pricewaterhouse
Coopers Pvt. Ltd., says, “joint ventures between domestic and global players are
mainly to hare risks, avoid heavy government regulations, access to new market
and capital and to get competitive edge.” He added, “Nature of the joint
ventures are mainly technical, financial and technical –cum-financial
collaboration. Selection of a partner is based on technical competencies,
previous relationship, reputation and brand strength, financial standing, tenure
of joint venture and management quality and capacity.”
The sources said that several global firms found it cost effective to work with
Indian partners in the form of technical collaborations and joint ventures and
thus can produce high quality machines at affordable process. The Mumbai based
ACG World Wide, a leading player in the segment, has collaborated with VAW of
Germany, Glatt of Germany and IWKA of Germany. Elmach Packages India Pvt. Ltd.
has tied-up with German companies like Weipack and Merz. It is learnt that
several other players are also expected to enter collaborations and joint
ventures with the overseas firms in the future.
Commenting on the collaborations with the overseas firms, Piyush Tripadi,
managing director of the Ahmedabad based Sree Bhagawati Pharma Machinery, says,
“The joint ventures and collaborations with the international firms will provide
the Indian companies access to new geographical locations and the latest
know-how in the machine manufacturing segment.
(Ref: The Chronicle Pharmabiz dated November 15, 2007)
Solvay Advanced Polymers Launches Biomaterials For Use in Implantable Medical
Solvay Advanced Polymers announced at the recently concluded K-Show the launch
of its Solviva™ family of biomaterials offered for use in implantable medical
devices. As per the Company sources, no other supplier has more polymers
available for use in implantable applications than Solvay Advanced Polymers with
its Solviva line of biomaterials.
Solviva Biomaterials are comprised of :
Zeniva™ PEEK (polyethere-therketone) – one of the most chemically resistant
plastics available, exhibiting high strength and stiffness along with excellent
toughness and fatigue resistance.
Proniva™ SRP (self-reinforced polyphenylene) – the stiffest and strongest
unreinforced thermoplastic available, offering exceptional chemical resistance
Veriva™ PPSU (polyphenylsulfone) – offers unsurpassed toughness combined with
transparency and excellent chemical resistance.
Eviva™ PSU (polysulfone) – offers practical toughness in a strong, transparent
“We are very proud to leverage our technology in creating this family of
products,” commented Roger Kearns, President & CEO of Solvay Advanced Polymers.
“The ability to supply our customers with biomaterials that are the foundation
for products that may help to extend and improve the quality of life in critical
healthcare applications is tremendously rewarding.’’